Navigation Links
Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
Date:2/29/2008

KENILWORTH, N.J., Feb. 29 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP) today approved an expanded role and promotion for Ian McInnes, Ph.D., to senior vice president and president, Global Supply Chain. He had been senior vice president, Global Supply Chain. The change reflects the new scope of the company's global supply chain strategy that now includes operations from Organon BioSciences N.V., acquired in November 2007.

McInnes, an adviser to Schering-Plough's Executive Management Team, is responsible for more than 60 manufacturing sites worldwide. His responsibility for Global Supply Chain operations includes the supply of products to Schering-Plough's customers to meet market requirements, as well as the development and implementation of a global manufacturing strategy that integrates all manufacturing facilities worldwide. These include facilities for human prescription medicines and for animal health and consumer health care products. McInnes additionally is responsible for the company's global procurement activities.

McInnes joined Schering-Plough as senior vice president, Global Supply Chain, in May 2004. He holds both a B.S. degree in manufacturing technology and manufacturing management and a Ph.D. degree in manufacturing engineering and systems from the University of Strathclyde in Glasgow, Scotland.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to anima
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
6. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
7. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
8. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
9. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
10. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
11. Schering-Plough CEO to Buy $2 Million in Common Shares

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...PRNewswire/ -- A randomized, controlled study comp... invasive treatment called percutaneous disc decom...while both treatments help patients in the short r...e up to two years later. Results of the study, the...nual meeting of the Radiological Society of North ...
(Date:12/2/2009)...c. 2 LeapFrog Investments has anno...ent in AllLife, the innovative South African insur...e investment brings together LeapFrog, the leading...of Africa,s most innovative insurance businesses. ...,, "AllLife has developed a distinctive and pro...
(Date:12/2/2009)...trasound of suspicious areas of the breast, includ...alternative to invasive biopsies for women under a...esented today at the annual meeting of the Radiolo...forming high-quality breast ultrasound, we can red... diagnostic procedures in young women," said senio...
(Date:12/2/2009)...-scale clinical trial presented today at the annua...rica (RSNA) provide the first strong evidence of t...n with dense breasts who are at elevated risk for ...at MRI is highly sensitive in depicting early brea...h ultrasound in addition to mammography significan...
(Date:12/1/2009)...ocate Christ Medical Center in Oak Lawn, Ill. has ...center and the first for Chicago’s south and...he hospital’s plans today (December 1) by th...oard. , Springfield, Ill....k Lawn, Ill. has become the state’s newest k...
Breaking Medicine News(10 mins):Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3
...rgery, most people want reduction of fat in abdome...involves a procedure wherein the body fat is conve...uction is one of the most popular cosmetic surgery...practically non-invasive it is also known as key-h...
... contains 12 times more iron compared to breast mi...egeneration, seen in Parkinson’s disease can be ca...ds a study with neonatal mice which was fed with h..., compared to those without the incurable, progres...
...h has revealed that experimental dietary regimens ...disease//. The study, which appears in the July..., is the first to show that restricting caloric in...l evidence suggests that modification of lifestyle...
...sai Co. Ltd, charity organizations, The Alzheimer'...Age Concern will appeal have lodged// an appeal on...estrict access to Alzheimer's drugs. The Nat... drugs that could help but not cure patients with ...
... high risk of developing diabetics. The number of ... Statistics show that in the next 25 years time// ...betes. The Scottish Executives are keen on combat...So far the number of people diagnosed with the dis...
...man aged 64, and woman aged 81, affected with legi...l,Sydney, after being exposed// to the same type ...man‘s condition is reported to be serious, while t...d out by the Health officials to identify the sou...
Other Medicine News:Health News:Infant Formula With High Iron Content Packs Brain Disorder 2Health News:Infant Formula With High Iron Content Packs Brain Disorder 3Health News:Restriction of Carbohydrates to Prevent Alzheimer's Disease 2Health News:Restriction of Carbohydrates to Prevent Alzheimer's Disease 3Health News:Appeals Against The New Resolution By NICE Increases 2
(Date:12/1/2009)... -- Reportlinker.com announces that a new market r..., The Future of Oncology Therapeutics - Market Fo... Pipeline and Deals Analysis ,, http://www.re...rapeutics---Market-Forecasts-to-2015-Competitive-B...ml ,, Summary ,, The author has released ...
(Date:12/1/2009)...ation reduction in cardiac CT scans ,, CHICAGO,..., a radiologist from Fairfax Radiological Consulta...findings of a study that shows a 90 percent reduct...ived from CT scans compared to scans performed two...dy to the annual meeting of the Radiological Socie...
(Date:12/1/2009)...c. 1 Former New Jersey A...ted when his radiotherapy treatment sessions for p... to less than five. Midway through his course of ... Cancer Center acquired the region,s first Rapi...dical Systems (NYSE: VAR ), making it possible f...
Breaking Medicine Technology:Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Many Health Care Workers May Shun Swine Flu Shot 55387 1Many Health Care Workers May Shun Swine Flu Shot 55387 2Danaher to Present at Morgan Stanley Global Industrials Conference 55383 1Waste Management and Terrabon Announce Investment Agreement for Waste To Fuel Conversion Technology 13694 1Waste Management and Terrabon Announce Investment Agreement for Waste To Fuel Conversion Technology 13694 2Waste Management and Terrabon Announce Investment Agreement for Waste To Fuel Conversion Technology 13694 3Waste Management and Terrabon Announce Investment Agreement for Waste To Fuel Conversion Technology 13694 4
...product in,AM-Pharma,s pipeline , BUNNIK, The Neth...armaceutical company developing novel therapeutics...day announced positive,results in patients with Ac...bgroup of a Phase IIa trial with Alkaline Phosphat..., a marker for renal function,improved by 45% (me...
...Institut (SSI) and Intercell, report promising d...tuberculosis (TB) subunit vaccine , , » ... Intercell’s,adjuvant IC31™ , , &raq...e European Union aims to,either , replace t...almette vaccine” or,to , boost its ac...
Other Medicine Technology:AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 2AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 2Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 3Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile 4
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: